These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 9488046)

  • 21. Mapping of the tyrosine kinase receptors trkA (NTRK1), trkB (NTRK2) and trkC(NTRK3) to human chromosomes 1q22, 9q22 and 15q25 by fluorescence in situ hybridization.
    Valent A; Danglot G; Bernheim A
    Eur J Hum Genet; 1997; 5(2):102-4. PubMed ID: 9195161
    [TBL] [Abstract][Full Text] [Related]  

  • 22. IRS-1 and IRS-2 are recruited by TrkA receptor and oncogenic TRK-T1.
    Miranda C; Greco A; Miele C; Pierotti MA; Van Obberghen E
    J Cell Physiol; 2001 Jan; 186(1):35-46. PubMed ID: 11147812
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Early evolutionary origin of the neurotrophin receptor family.
    van Kesteren RE; Fainzilber M; Hauser G; van Minnen J; Vreugdenhil E; Smit AB; Ibáñez CF; Geraerts WP; Bulloch AG
    EMBO J; 1998 May; 17(9):2534-42. PubMed ID: 9564036
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Crystal structures of the neurotrophin-binding domain of TrkA, TrkB and TrkC.
    Ultsch MH; Wiesmann C; Simmons LC; Henrich J; Yang M; Reilly D; Bass SH; de Vos AM
    J Mol Biol; 1999 Jul; 290(1):149-59. PubMed ID: 10388563
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rearrangements of NTRK1 gene in papillary thyroid carcinoma.
    Greco A; Miranda C; Pierotti MA
    Mol Cell Endocrinol; 2010 May; 321(1):44-9. PubMed ID: 19883730
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sustained in vivo regression of Dunning H rat prostate cancers treated with combinations of androgen ablation and Trk tyrosine kinase inhibitors, CEP-751 (KT-6587) or CEP-701 (KT-5555).
    George DJ; Dionne CA; Jani J; Angeles T; Murakata C; Lamb J; Isaacs JT
    Cancer Res; 1999 May; 59(10):2395-401. PubMed ID: 10344749
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular characterization of human trk proto-oncogene product monoclonal antibodies.
    Eager KB
    Oncogene; 1991 May; 6(5):819-24. PubMed ID: 2052359
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cloning and chromosomal localization of the human TRK-B tyrosine kinase receptor gene (NTRK2).
    Nakagawara A; Liu XG; Ikegaki N; White PS; Yamashiro DJ; Nycum LM; Biegel JA; Brodeur GM
    Genomics; 1995 Jan; 25(2):538-46. PubMed ID: 7789988
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biochemical and functional characterization of the murine ros protooncogene.
    Riethmacher D; Langholz O; Gödecke S; Sachs M; Birchmeier C
    Oncogene; 1994 Dec; 9(12):3617-26. PubMed ID: 7970722
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The RFG oligomerization domain mediates kinase activation and re-localization of the RET/PTC3 oncoprotein to the plasma membrane.
    Monaco C; Visconti R; Barone MV; Pierantoni GM; Berlingieri MT; De Lorenzo C; Mineo A; Vecchio G; Fusco A; Santoro M
    Oncogene; 2001 Feb; 20(5):599-608. PubMed ID: 11313992
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CEP-751 inhibits TRK receptor tyrosine kinase activity in vitro exhibits anti-tumor activity.
    Camoratto AM; Jani JP; Angeles TS; Maroney AC; Sanders CY; Murakata C; Neff NT; Vaught JL; Isaacs JT; Dionne CA
    Int J Cancer; 1997 Aug; 72(4):673-9. PubMed ID: 9259409
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of STAT3 in in vitro transformation triggered by TRK oncogenes.
    Miranda C; Fumagalli T; Anania MC; Vizioli MG; Pagliardini S; Pierotti MA; Greco A
    PLoS One; 2010 Mar; 5(3):e9446. PubMed ID: 20209132
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oncogenic activation of the human trk proto-oncogene by recombination with the ribosomal large subunit protein L7a.
    Ziemiecki A; Müller RG; Fu XC; Hynes NE; Kozma S
    EMBO J; 1990 Jan; 9(1):191-6. PubMed ID: 2403926
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An in vivo functional genetic screen reveals a role for the TRK-T3 oncogene in tumor progression.
    Edel MJ; Shvarts A; Medema JP; Bernards R
    Oncogene; 2004 Jun; 23(29):4959-65. PubMed ID: 15077169
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A TFG-TEC nuclear localization mutant forms complexes with the wild-type TFG-TEC oncoprotein and suppresses its activity.
    Lim B; Kim AY; Jun HJ; Kim J
    Biochem J; 2013 Dec; 456(3):361-72. PubMed ID: 24073693
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular cloning of trkE, a novel trk-related putative tyrosine kinase receptor isolated from normal human keratinocytes and widely expressed by normal human tissues.
    Di Marco E; Cutuli N; Guerra L; Cancedda R; De Luca M
    J Biol Chem; 1993 Nov; 268(32):24290-5. PubMed ID: 8226977
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regulation of c-Fes tyrosine kinase and biological activities by N-terminal coiled-coil oligomerization domains.
    Cheng H; Rogers JA; Dunham NA; Smithgall TE
    Mol Cell Biol; 1999 Dec; 19(12):8335-43. PubMed ID: 10567558
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeting tropomyosin-receptor kinase fused gene in cancer.
    Chen Y; Tseng SH
    Anticancer Res; 2014 Apr; 34(4):1595-600. PubMed ID: 24692687
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human trk oncogenes activated by point mutation, in-frame deletion, and duplication of the tyrosine kinase domain.
    Coulier F; Kumar R; Ernst M; Klein R; Martin-Zanca D; Barbacid M
    Mol Cell Biol; 1990 Aug; 10(8):4202-10. PubMed ID: 1695324
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rapid physical mapping of the human trk protooncogene (NTRK1) to human chromosome 1q21-q22 by P1 clone selection, fluorescence in situ hybridization (FISH), and computer-assisted microscopy.
    Weier HU; Rhein AP; Shadravan F; Collins C; Polikoff D
    Genomics; 1995 Mar; 26(2):390-3. PubMed ID: 7601468
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.